Cochrane Abstracts
Immunosuppressive treatment for proliferative lupus nephritis: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunosuppressive Treatment for Proliferative Lupus Nephritis: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438483/2/Self���management_interventions_including_action_plans_for_exacerbations_versus_usual_care_in_patients_with_chronic_obstructive_pulmonary_disease_New.
Immunosuppressive treatment for proliferative lupus nephritis: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438483/2/Self���management_interventions_including_action_plans_for_exacerbations_versus_usual_care_in_patients_with_chronic_obstructive_pulmonary_disease_New. Accessed July 16, 2025.
Immunosuppressive treatment for proliferative lupus nephritis: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438483/2/Self���management_interventions_including_action_plans_for_exacerbations_versus_usual_care_in_patients_with_chronic_obstructive_pulmonary_disease_New
Immunosuppressive Treatment for Proliferative Lupus Nephritis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438483/2/Self���management_interventions_including_action_plans_for_exacerbations_versus_usual_care_in_patients_with_chronic_obstructive_pulmonary_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunosuppressive treatment for proliferative lupus nephritis: Cochrane systematic review
ID - 438483
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438483/2/Self���management_interventions_including_action_plans_for_exacerbations_versus_usual_care_in_patients_with_chronic_obstructive_pulmonary_disease_New
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
